Hyperliquid Strategies Inc. (PURR)
NASDAQ: PURR · Real-Time Price · USD
3.550
-0.030 (-0.84%)
Jan 9, 2026, 4:00 PM EST - Market closed
Company Description
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York.
Hyperliquid Strategies Inc.
| Country | United States |
| Founded | 2025 |
| Industry | Capital Markets |
| Sector | Financials |
| CEO | David Schamis |
Contact Details
Address: 477 Madison Avenue New York, New York 10022 United States |
Stock Details
| Ticker Symbol | PURR |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Reporting Currency | USD |
| CIK Code | 0002078856 |
| CUSIP Number | 44916Y106 |
| ISIN Number | US44916Y1064 |
Key Executives
| Name | Position |
|---|---|
| David Schamis | Chief Executive Officer |
| Brett Beldner | Chief Financial Officer |
| Jeroen Nieuwkoop | Chief Operating Officer |